IO Biotech, Inc. (IOBT) Misses Q2 EPS by 3c

IO Biotech, Inc. (NASDAQ: IOBT) reported Q2 EPS of ($0.40), $0.03 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on IO Biotech, Inc. (IOBT) click here.

You May Also Be Interested In

• Verizon to cut 3,000 jobs as it shifts stores to franchises
• CareDx, Inc (CDNA) PT Raised to $45 at BTIG
• White House: Trump will attend World Cup final